A rapidly growing Greater Cincinnati startup that counts Mark Cuban and Avondale-based CincyTech as investors has raised millions in new funding.
Mason-based Genetesis – whose flagship technology, CardioFlux, can rapidly scan for various heart conditions without the use of any radiation, contrast or exercise – has closed $17.5 million in Series C financing. The company announced the news Thursday.
The round was led by Austin, Texas-based Mithril Capital, a venture firm co-founded by famed…
